Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Lloyd

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Neuroinflammation|July 2, 2008
Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injuryEric Lloyd, Kathleen Somera-Molina, Linda J Van Eldik, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 16, 2022
Efficacy and Safety of Lisdexamfetamine in Preschool Children With Attention-Deficit/Hyperactivity DisorderAnn C Childress, Eric Lloyd, Leslie Jacobsen, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 6, 2018
Long-term efficacy and tolerability of azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide in chronic kidney diseaseGeorge L Bakris, Lin Zhao, Stuart Kupfer, et al.
Perfusion|February 24, 2024
Negative pressure therapy for ECMO cannula stabilizationJennifer Gauntt, Virginia Kathleen Cox, Vicky Duffy, et al.
Vaccine|September 4, 2020
Efficacy of an intramuscular bivalent norovirus GI.1/GII.4 virus-like particle vaccine candidate in healthy US adultsJames Sherwood, Paul M Mendelman, Eric Lloyd, et al.
Toxicologic Pathology|October 10, 2002
Evaluation of carcinogenic responses in the Eker rat following short-term exposure to selected nephrotoxins and carcinogensLaura Dill Morton, Ashraf F Youssef, Eric Lloyd, et al.
The Journal of Infectious Diseases|April 20, 2019
Persistence of Antibodies to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: 1-Year Follow-up With Memory Probe VaccinationRobert L Atmar, Frank Baehner, Jakob P Cramer, et al.
Arthritis Research & Therapy|April 8, 2010
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trialMichael A Becker, H Ralph Schumacher, Luis R Espinoza, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 11, 2018
Efficacy and safety of azilsartan medoxomil/chlortalidone fixed-dose combination in hypertensive patients uncontrolled on azilsartan medoxomil alone: A randomized trialDavid J Collier, Attila Juhasz, Enrico Agabiti-Rosei, et al.
The American Journal of Cardiology|September 16, 2018
Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic HypertensionKeith C Ferdinand, George L Bakris, William C Cushman, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Neuroinflammation|July 2, 2008
Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injuryEric Lloyd, Kathleen Somera-Molina, Linda J Van Eldik, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 16, 2022
Efficacy and Safety of Lisdexamfetamine in Preschool Children With Attention-Deficit/Hyperactivity DisorderAnn C Childress, Eric Lloyd, Leslie Jacobsen, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 6, 2018
Long-term efficacy and tolerability of azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide in chronic kidney diseaseGeorge L Bakris, Lin Zhao, Stuart Kupfer, et al.
Perfusion|February 24, 2024
Negative pressure therapy for ECMO cannula stabilizationJennifer Gauntt, Virginia Kathleen Cox, Vicky Duffy, et al.
Vaccine|September 4, 2020
Efficacy of an intramuscular bivalent norovirus GI.1/GII.4 virus-like particle vaccine candidate in healthy US adultsJames Sherwood, Paul M Mendelman, Eric Lloyd, et al.
Toxicologic Pathology|October 10, 2002
Evaluation of carcinogenic responses in the Eker rat following short-term exposure to selected nephrotoxins and carcinogensLaura Dill Morton, Ashraf F Youssef, Eric Lloyd, et al.
The Journal of Infectious Diseases|April 20, 2019
Persistence of Antibodies to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: 1-Year Follow-up With Memory Probe VaccinationRobert L Atmar, Frank Baehner, Jakob P Cramer, et al.
Arthritis Research & Therapy|April 8, 2010
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trialMichael A Becker, H Ralph Schumacher, Luis R Espinoza, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 11, 2018
Efficacy and safety of azilsartan medoxomil/chlortalidone fixed-dose combination in hypertensive patients uncontrolled on azilsartan medoxomil alone: A randomized trialDavid J Collier, Attila Juhasz, Enrico Agabiti-Rosei, et al.
The American Journal of Cardiology|September 16, 2018
Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic HypertensionKeith C Ferdinand, George L Bakris, William C Cushman, et al.
Pageof 3